腹部原发恶性肿瘤患者肺结节的PET/MRI评估:敏感性与结局分析
本研究回顾性纳入126例腹部原发恶性肿瘤患者的[18F]-FDG PET/MR,以6周内诊断性胸部CT或PET/CT为标准参照,评估PET/MR对肺结节的检出敏感性及漏诊结节的生长与临床管理影响。PET/MR患者水平敏感性28.1%、结节水平12.1%,对>7 mm结节敏感性更高;22.3%的漏诊结节随访增大,但漏诊结节未影响患者管理。
要点
- PET/MR对肺结节检出敏感性低于标准胸部影像,且受结节大小影响。
- 漏诊结节中22.3%随访增大,可能代表转移。
- 在本组以胸外晚期癌症为主的患者中,漏诊结节未改变临床管理。
核心结论
- PET/MR肺结节检出敏感性受结节大小影响且低于标准胸部影像,22.3%漏诊结节随访增大可能为转移,但未影响本组患者临床管理。
研究设计与样本
- 回顾性IRB批准研究,纳入126例腹部原发恶性肿瘤患者的[18F]-FDG PET/MR,以6周内诊断性胸部CT或PET/CT为标准参照,由两名放射科医师评估结节。
- 对PET/MR漏诊结节随访标准胸部影像评估生长(≥2 mm)并分析对管理的影响。
主要发现
- 标准胸部影像在89/126例患者中检出505个结节(平均4 mm,范围1-23 mm)。
- PET/MR检出61个结节,患者水平敏感性28.1%,结节水平12.1%,对>7 mm结节敏感性更高(分别<30%和>70%,p<0.05)。
- 75/337(22.3%)漏诊结节随访(平均736天)显示增大。
- 标准胸部影像有结节而PET/MR阴性的患者中,漏诊结节未影响患者管理。
关键数值与推荐
- PET/MR结节水平敏感性12.1%,患者水平敏感性28.1%。
- 漏诊结节随访增大比例为22.3%(75/337)。
- 结节生长判定阈值为≥2 mm。
临床怎么用
- 在腹部原发恶性肿瘤(尤其胸外晚期)患者中,PET/MR不能替代标准胸部影像评估肺结节。
- 对PET/MR阴性的肺结节需结合标准胸部影像,并关注>7 mm结节的检出。
局限性
- 研究为回顾性设计,结论主要适用于以胸外晚期癌症为主的人群,对无胸外播散患者的意义可能不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate PET/MR lung nodule detection compared to PET/CT or CT, to determine growth of nodules missed by PET/MR, and to investigate the impact of missed nodules on clinical management in primary abdominal malignancies. METHODS: This retrospective IRB-approved study included [18F]-FDG PET/MR in 126 patients. All had standard of care chest imaging (SCI) with diagnostic chest CT or PET/CT within 6 weeks of PET/MR that served as standard of reference. Two radiologists assessed lung nodules (size, location, consistency, position, and [18F]-FDG avidity) on SCI and PET/MR. A side-by-side analysis of nodules on SCI and PET/MR was performed. The nodules missed on PET/MR were assessed on follow-up SCI to ascertain their growth (≥ 2 mm); their impact on management was also investigated. RESULTS: A total of 505 nodules (mean 4 mm, range 1-23 mm) were detected by SCI in 89/126 patients (66M:60F, mean age 60 years). PET/MR detected 61 nodules for a sensitivity of 28.1% for patient and 12.1% for nodule, with higher sensitivity for > 7 mm nodules (< 30% and > 70% respectively, p < 0.05). 75/337 (22.3%) of the nodules missed on PET/MR (follow-up mean 736 days) demonstrated growth. In patients positive for nodules at SCI and negative at PET/MR, missed nodules did not influence patients' management. CONCLUSIONS: Sensitivity of lung nodule detection on PET/MR is affected by nodule size and is lower than SCI. 22.3% of missed nodules increased on follow-up likely representing metastases. Although this did not impact clinical management in study group with primary abdominal malignancy, largely composed of extra-thoracic advanced stage cancers, with possible different implications in patients without extra-thoracic spread.
引用
- Biondetti P, Vangel MG, Lahoud RM, et al. PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis. Eur J Nucl Med Mol Imaging. 2021. PMID: 33415433. doi:10.1007/s00259-020-05113-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。